Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Sponsors Fellow to Develop Cancer Assays at UK's DxS

NEW YORK  (GenomeWeb News) - AstraZeneca and the University of Manchester are placing a Clinical Research Fellow at DxS to work on a project to identify circulating DNA tumor markers in blood.
 
The focus of the three-year project will initially be to develop assays for genes that show prevalent mutations in cancer.  It is supported by AstraZeneca and Cancer Research UK.
 
DxS will help the fellow, unnamed in a press release, to develop the assays using the company's Scorpions and ARMS technologies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.